Search

M2 PHARMA-November 4, 2024-Futura Medical reports positive developments in product pipeline (C)2024 M2 COMMUNICATIONS Futura Medical plc (AIM: FUM), a consumer healthcare company known for Eroxon, on Monday announced encouraging [...]

M2 EQUITYBITES-November 4, 2024-Futura Medical reports positive developments in product pipeline (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk Futura Medical plc (AIM: FUM), a consumer healthcare company known for Eroxon, on Monday announced [...]

Stockholm: IRLAB Therapeutics AB has issued the following news release: IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that [...]

> Industry Seeks Global Regulatory Certainty and Consistency AI stands to transform medical product development by creating efficiencies that shrink timelines and costs, and by producing insights. In fact, according [...]

CINCINNATI: LIB Therapeutics, Inc. announces that its regional partner in China, Hasten Biopharmaceuticals Co, Ltd. (Hasten), has received notification of acceptance for the clinical trial application for Lerodalcibep by the [...]

- Application based on integrated global data dossier completed for Lerodalcibep by LIB - Hasten to begin bridging studies to support planned BLA submission in China CINCINNATI -- LIB Therapeutics, [...]

Small purchase:907-u690-24/3 provision of services to support clinical trials in the form of a comparative analysis of medical products: instruments and devices for osteosynthesis, instruments and implants for osteosynthesis, external [...]

M2 PRESSWIRE-February 6, 2024-: GSK's regulatory application for Shingrix for the prevention of shingles in at-risk adults aged 18 and over accepted for review by China National Medical Products Administration [...]

Brentford, London, United: GlaxoSmithKline has issued the following press release: today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted for [...]

GSK plc announced on 6 Feb 2024 that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted for review the regulatory application of Shingrix (Recombinant Zoster Vaccine or RZV) for the prevention of shingles (herpes zoster) in adults aged 18 years and over at increased risk. Recombinant Zoster Vaccine (RZV) is a non-live, recombinant subunit adjuvanted vaccine given intramuscularly in two doses and was initially approved in 2019 by the NMPA to prevent shingles in adults aged 50 years and over. The NMPA application is informed by six clinical trials in patients aged 18 years and over who had undergone recent blood-forming cells (stem cell) transplantation, kidney transplant, or have blood cancer, solid tumour, or HIV. Original source: GlaxoSmithKline, website: http://www.gsk.com/, Copyright GlaxoSmithKline plc 2024., regulations and rulings; antiviral vaccines; Shingrix; [...]

2024 JUN 10 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Fresh data on pulpotomy are presented in a new report. According to news reporting [...]

SILVER SPRING, MD -- The following information was released by the U.S. Food and Drug Administration (FDA): The purpose of this guidance is to provide FDA's expectations for, and recommendations [...]

United Kingdom based Oxford Medical Devices Ltd has secured contract from UNIVERSITY OF EAST ANGLIA for Provision of consultancy and product developments for CAVA medical device and associated software. The [...]

SILVER SPRING, MD -- The following information was released by the U.S. Food and Drug Administration (FDA): By: Robert M. Califf, M.D., Commissioner of Food and Drugs Earlier this month [...]

SILVER SPRING, MD -- The following information was released by the U.S. Food and Drug Administration (FDA): This guidance recommends approaches that sponsors of clinical trials of medical products can [...]

CHENGDU: WestVac BioPharma Co., Ltd has issued the following news release: On May 17, 2023, Recombinant bivalent COVID-19 protein vaccine (Sf9 cells) and recombinant trivalent COVID-19 trimeric protein vaccine (Sf9 [...]

CHENGDU, China, May 18, 2023 /PRNewswire/ -- On May 17, 2023, Recombinant bivalent COVID-19 protein vaccine (Sf9 cells) and recombinant trivalent COVID-19 trimeric protein vaccine (Sf9 cells) developed by WestVac [...]

MAHWAH: KORU Medical Systems, Inc., ('KORU Medical'), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality [...]

MAHWAH, N.J.--(BUSINESS WIRE)--Jan 25, 2023-- KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous [...]

MAHWAH, N.J. -- KORU Medical Systems, Inc. (NASDAQ: KRMD) ('KORU Medical'), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery [...]

United Kingdom based MODEPHARMA LIMITED has secured contract from UNIVERSITY OF BIRMINGHAM for Contract for the Provision of Clinical Trials Services to the LOCI Trial Manufacture (package, label) and Distribute [...]

2023 MAR 12 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Data detailed on Biomedical Engineering - Fibrin Tissue Adhesives have been [...]

M2 PHARMA-January 25, 2023-KORU Medical Systems signs SCIg prefilled syringe development agreement (C)2023 M2 COMMUNICATIONS Medical technology company KORU Medical Systems Inc (NASDAQ:KRMD) announced on Wednesday a new agreement to [...]

M2 EQUITYBITES-January 25, 2023-KORU Medical Systems signs SCIg prefilled syringe development agreement (C)2023 M2 COMMUNICATIONS http://www.m2.co.uk Medical technology company KORU Medical Systems Inc (NASDAQ:KRMD) announced on Wednesday a new agreement [...]

SILVER SPRING, MD -- The following information was released by the U.S. Food and Drug Administration (FDA): FDA is developing a series of four methodological patient-focused drug development (PFDD) guidance [...]

Hong Kong: Mabpharm Limited has issued the following announcement: This announcement is made by Mabpharm Limited (the 'Company', together with its subsidiaries, the 'Group') on a voluntary basis to inform [...]

Hong Kong: Shanghai Henlius Biotech, Inc. has issued the following announcement: This announcement is made by Shanghai Henlius Biotech, Inc. (the 'Company') on a voluntary basis to inform the shareholders [...]

STOCKHOLM: Promore Pharma has issued the following news release: Promore Pharma (STO:PROMO)(FRA:8T0) Stockholm, November 9, 2021 - Promore Pharma AB, a Swedish biopharmaceutical company that develops peptide-based drug candidates, announced [...]

Hong Kong: China Medical System Holdings Limited has issued the following announcement: China Medical System Holdings Limited (the 'Company', together with its subsidiaries, the 'Group') is pleased to announce that [...]

ImmVira announced that as a global first, its lead oncolytic virus therapy program MVR-T3011 IV (also known as T3011), obtained approval from National Medical Products Administration ('NMPA') for clinical trial [...]

SHENZHEN, China, Aug. 6, 2021 /PRNewswire/ -- ImmVira announced that as a global first, its lead oncolytic virus therapy program MVR-T3011 IV (also known as T3011), obtained approval from National [...]

Busan, Korea, South, May 13, 2021 --(PR.com)-- Mika Medical, a Korean manufacturer specializing in syringe technology, namely the Comfort-in needleless syringe, has completed clinical trials with Yonsei University Severance Hospital [...]

Mika Medical, a Korean manufacturer specializing in syringe technology, namely the Comfort-in needleless syringe, has completed clinical trials with Yonsei University Severance Hospital and Catania University Medical School in Italy [...]

Hong Kong: Shanghai Henlius Biotech, Inc. has issued the following announcement: This announcement is made by Shanghai Henlius Biotech, Inc. (the 'Company') on a voluntary basis to inform the shareholders [...]

SHANGHAI: Citrine Medicine has issued the following news release: Citrine Medicine, a China-based rare disease therapeutics company, today announced that it has received a clinical trial waiver from the National [...]

Citrine Medicine, a China-based rare disease therapeutics company, today announced that it has received a clinical trial waiver from the National Medical Products Administration (NMPA) in China for Wakix (pitolisant), [...]

Tenders are invited for delivery of medical products for clinical trials for the state healthcare institution 'tula regional clinical hospital' In accordance with tz Major organization : STATE STATE INSTITUTION [...]

SILVER SPRING, MD -- The following information was released by the U.S. Food and Drug Administration (FDA): As the public health agency responsible for regulating medical products, we must ensure [...]

Marinus and Ceribell, Inc. agree to place handheld Ceribell Rapid Response EEG systems in hospitals in connection with its Phase 3 RSE clinical trial RADNOR, Pa. -- Marinus Pharmaceuticals, Inc. [...]

BEIJING: EdiGene, Inc. has issued the following news release: EdiGene, Inc. ( 'Company', or 'EdiGene'), today announced the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) [...]

BEIJING & CAMBRIDGE, Mass. -- EdiGene, Inc. ( 'Company', or 'EdiGene'), today announced the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) has approved the Company's [...]

Hong Kong: Shanghai Henlius Biotech, Inc. has issued the following announcement: This announcement is made by Shanghai Henlius Biotech, Inc. (the 'Company') on a voluntary basis to inform the shareholders [...]

Hong Kong: Shanghai Henlius Biotech, Inc. has issued the following announcement: This announcement is made by Shanghai Henlius Biotech, Inc. (the 'Company') on a voluntary basis to inform the shareholders [...]

SILVER SPRING, MD -- The following information was released by the U.S. Food and Drug Administration (FDA): Statement From: Statement Author Leadership Role Commissioner of Food and Drugs - Food [...]

Hong Kong: Everest Medicines Limited has issued the following announcement: This announcement is made by Everest Medicines Limited (the 'Company') on a voluntary basis to inform the shareholders and potential [...]

SHANGHAI, China, Nov 01, 2020 (GLOBE NEWSWIRE via COMTEX) -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical [...]

BEIJING: EdiGene, Inc. has issued the following news release: EdiGene, Inc. ( 'Company', or 'EdiGene'), today announced the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) [...]

BEIJING & CAMBRIDGE, Mass. -- EdiGene, Inc. ( 'Company', or 'EdiGene'), today announced the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) has accepted for review [...]

As the COVID-19 pandemic continues to alter ways of life across the globe, clinical trials must be adapted for participant safety while maintaining accuracy in the midst of the ongoing [...]